[go: up one dir, main page]

AU2002360517A1 - Respiratory infection prevention and treatment with terpene-containing compositions - Google Patents

Respiratory infection prevention and treatment with terpene-containing compositions

Info

Publication number
AU2002360517A1
AU2002360517A1 AU2002360517A AU2002360517A AU2002360517A1 AU 2002360517 A1 AU2002360517 A1 AU 2002360517A1 AU 2002360517 A AU2002360517 A AU 2002360517A AU 2002360517 A AU2002360517 A AU 2002360517A AU 2002360517 A1 AU2002360517 A1 AU 2002360517A1
Authority
AU
Australia
Prior art keywords
terpene
treatment
containing compositions
respiratory infection
infection prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002360517A
Inventor
Lanny U. Franklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ximed Group PLC
Original Assignee
Ximed Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ximed Group PLC filed Critical Ximed Group PLC
Publication of AU2002360517A1 publication Critical patent/AU2002360517A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002360517A 2001-12-07 2002-12-09 Respiratory infection prevention and treatment with terpene-containing compositions Abandoned AU2002360517A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33662801P 2001-12-07 2001-12-07
US60/336,628 2001-12-07
PCT/US2002/039196 WO2003049726A1 (en) 2001-12-07 2002-12-09 Respiratory infection prevention and treatment with terpene-containing compositions

Publications (1)

Publication Number Publication Date
AU2002360517A1 true AU2002360517A1 (en) 2003-06-23

Family

ID=23316950

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002360517A Abandoned AU2002360517A1 (en) 2001-12-07 2002-12-09 Respiratory infection prevention and treatment with terpene-containing compositions

Country Status (4)

Country Link
US (1) US20030180349A1 (en)
EP (1) EP1455768A1 (en)
AU (1) AU2002360517A1 (en)
WO (1) WO2003049726A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248764A1 (en) * 2001-08-28 2004-12-09 Franklin Lanny U Treatment and prevention of infections in plants
PL369238A1 (en) * 2001-12-18 2005-04-18 Henkel Kommanditgesellschaft Auf Aktien Inhibition of the asexual reproduction of fungi
US20030231978A1 (en) * 2002-02-19 2003-12-18 Franklin Lanny U. Indoor air quality and antiseptic composition for use therein
US20040131567A1 (en) * 2002-07-08 2004-07-08 Wilkins Joe S. Antibacterial topical formulations
MXPA05013790A (en) * 2003-06-17 2006-03-13 Henkel Kgaa Inhibition of the asexual reproduction of fungi by eugenol and/or the derivatives thereof.
AP2195A (en) 2004-01-23 2011-01-10 Eden Research Plc Methods of killing nematodes comprising the application of a terpene component.
US20050170052A1 (en) * 2004-02-02 2005-08-04 Pimentel Julio L. Water and feed preservative for animal uses
EP2338332B1 (en) * 2004-05-20 2014-02-12 Eden Research Plc Hollow glucan particle or cell wall particle encapsulating a terpene component
WO2006087039A1 (en) * 2005-02-17 2006-08-24 Propharex Sa Broad spectrum anti viral herbal composition
WO2006120496A1 (en) * 2005-05-13 2006-11-16 Advanced Scientific Developements Pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol and carvacrol
WO2006120494A1 (en) * 2005-05-13 2006-11-16 Advanced Scientific Developements Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol
EP1954130B1 (en) * 2005-11-30 2018-06-13 Eden Research Plc Methods comprising terpene mixtures comprising thymol and citral
EP1954129A1 (en) 2005-11-30 2008-08-13 Eden Research Plc Terpene-containing compositions and methods of making and using them
CN101677973A (en) * 2007-02-06 2010-03-24 奥里金生物医学股份有限公司 Compositions and methods for inhibiting nerve conduction comprising terpene compounds
EP1990047A1 (en) * 2007-05-11 2008-11-12 Aisa Therapeutics Use of a monoterpene to treat or prevent stress
AU2008316225B2 (en) 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
EP2100595A1 (en) * 2008-03-10 2009-09-16 The Procter and Gamble Company Compressed tablets
US9415023B2 (en) 2008-08-13 2016-08-16 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
CN102405044A (en) * 2009-02-06 2012-04-04 南加利福尼亚大学 Therapeutic compositions containing monoterpenes
AU2010242502B2 (en) 2009-04-30 2016-11-10 Avivagen Inc. Methods and compositions for improving the health of animals
CN104010500B (en) 2011-12-06 2016-06-15 荷兰联合利华有限公司 microbicide composition
MX354483B (en) 2011-12-06 2018-03-07 Unilever Nv Antimicrobial composition.
WO2013083592A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
BR112014013604B1 (en) 2011-12-06 2020-10-06 Unilever N.V. SYNERGISTIC MICROBICIDE COMPOSITION
EA025614B9 (en) 2011-12-06 2017-02-28 Юнилевер Н.В. Microbicidal composition
CN104080343A (en) 2011-12-06 2014-10-01 荷兰联合利华有限公司 Method for disinfecting a surface
EP2787824B1 (en) 2011-12-06 2015-12-02 Unilever N.V. Microbicidal composition
IN2014MN01019A (en) 2011-12-06 2015-09-11 Unilever Plc
US9504248B2 (en) 2011-12-06 2016-11-29 Rohm And Haas Company Antimicrobial composition
CN102526196A (en) * 2012-01-11 2012-07-04 刘永利 Externally applied plaster formulation for treating respiratory tract infection
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
CN105916492A (en) * 2013-10-31 2016-08-31 全谱实验室有限公司 Terpene and cannabinoid formulations
DE102016002890A1 (en) * 2016-03-09 2017-09-14 Forschungszentrum Jülich GmbH Process for the preparation of an ink, ink and their use
RU2616523C1 (en) * 2016-05-27 2017-04-17 Отия Варламович Сичинава Intranasal ointment for treatment and prevention of respiratory infection
CN108403834A (en) * 2018-05-25 2018-08-17 成都中医药大学 A kind of Herba Houttuyniae volatile oil Liposomal formulation and its preparation method and application
EP4014973B1 (en) * 2020-12-17 2025-04-23 Conick Biotech LLC Inhaled liquid for the treatment of respiratory infections in humans caused by pathogens resistant to antibiotics
US20220280734A1 (en) * 2021-03-07 2022-09-08 Sultan A. M. Daham Intaking an antiviral by inhalation or spraying for respiratory tract infection

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632782A (en) * 1967-01-13 1972-01-04 American Home Prod Thymol as an anti-influenza agent
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US5190977A (en) * 1988-06-24 1993-03-02 Stephen Herman Antiviral compositions
US5260342A (en) * 1988-06-24 1993-11-09 Stephen Herman Method for treating viral infection parenterally
US5547677A (en) * 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
DE69527624T2 (en) * 1994-05-20 2003-04-03 Novavax, Inc. ANTIMICROBIAL OIL-IN-WATER EMULSIONS
FR2727289B1 (en) * 1994-11-30 1999-03-05 Derives Resiniques Terpenique DISINFECTANT COMPOSITION COMPRISING AT LEAST ONE TERPENIC ALCOHOL AND AT LEAST ONE BACTERICIDAL ACID SURFACTANT, AND USE OF SUCH SURFACTANTS
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US5523078A (en) * 1995-02-03 1996-06-04 Michael E. Baylin Method of preparing and composition for treatment of hair and scalp
US5849956A (en) * 1995-02-08 1998-12-15 Plant Biological Defense System Laboratories Antifungal terpene compounds and process for producing the same
US5730989A (en) * 1995-02-16 1998-03-24 Novavax, Inc. Oral vaccine against gram negative bacterial infection
US5662957A (en) * 1996-05-03 1997-09-02 Novavax, Inc. Oil containing lipid vesicles with marine applications
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
US5939050A (en) * 1997-04-04 1999-08-17 Optiva Corp. Antimicrobial compositions
GT199800140A (en) * 1997-09-12 2000-02-29 ANTIMASTIC PHARMACEUTICAL COMPOSITION BASED ON EXTRACTS OF NATURAL ORIGIN AND PROCEDURES TO MANUFACTURE IT.
US5977186A (en) * 1998-01-27 1999-11-02 Ximed Group Plc Terpene treatments for killing lice and lice eggs
US6130253A (en) * 1998-01-27 2000-10-10 Ximed Group Plc Terpene based pesticide treatments for killing terrestrial arthropods including, amongst others, lice, lice eggs, mites and ants
WO2001025255A2 (en) * 1999-10-07 2001-04-12 Baylor College Of Medicine Novel zinc finger protein
US6447816B1 (en) * 2000-04-03 2002-09-10 Inhalation, Inc. Methods and apparatus to prevent colds, flus, and infections of the human respiratory system

Also Published As

Publication number Publication date
US20030180349A1 (en) 2003-09-25
WO2003049726A1 (en) 2003-06-19
EP1455768A1 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
AU2002360517A1 (en) Respiratory infection prevention and treatment with terpene-containing compositions
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
AU2002254158A1 (en) Medical devices, compositions and methods for treating vulnerable plaque
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU2002347614A1 (en) Antioxidant combination composition and use thereof
AU2002347152A1 (en) Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
IL162083A0 (en) Catheter composition and uses thereof
AU2003233445A1 (en) Antimicrobial compositions and methods of use
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU4671701A (en) Medical compositions comprising (r,r)-formoterol and rofleponide
AU2002346029A1 (en) Novel synergistic antimicrobial compositions and methods
AU2003275069A1 (en) Compositions and methods for preventing infection
AU2003303948A1 (en) Compositions and methods for preventing infection
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x
AU2001285141A1 (en) Human carboxylesterase family member and uses thereof
HK1065968A (en) Catheter composition and uses thereof
HK1067113A (en) Methods and compositions for treating or preventing bacterial infection
AU2001281747A1 (en) Composition and method for the treatment or prevention of hiv infection
AUPQ501000A0 (en) Compositions for the prevention and treatment of influenza
AU2002251847A1 (en) Vaccine and compositions for the prevention and treatment of neisserial infections
HK1069546A (en) Treatment of wounds and compositions employed

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase